Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
11 November 2019
| m 23:10 | Esophageal cancer (2 changes | history) . . (+844) . . [Jwarner (2×)] | ||
| m | 23:10 (cur | prev) . . (+854) . . Jwarner (talk | contribs) | ||
| m | 09:30 (cur | prev) . . (-10) . . Jwarner (talk | contribs) |
10 November 2019
| m 22:43 | Rectal cancer (diff | hist) . . (+426) . . Jwarner (talk | contribs) |
| m 22:41 | Cholangiocarcinoma (diff | hist) . . (+140) . . Jwarner (talk | contribs) |
| m 22:35 | Anal cancer (diff | hist) . . (+106) . . Jwarner (talk | contribs) |
| m 14:57 | Colon cancer (diff | hist) . . (+3,379) . . Jwarner (talk | contribs) |
9 November 2019
8 November 2019
7 November 2019
| 23:15 | Gastric cancer (10 changes | history) . . (+6,810) . . [Ivyabraham (3×); Jwarner (7×)] | ||
| m | 23:15 (cur | prev) . . (+181) . . Jwarner (talk | contribs) (→Metastatic or locally advanced disease, subsequent lines of therapy) | ||
| m | 23:10 (cur | prev) . . (+1,443) . . Jwarner (talk | contribs) (→S-1 monotherapy {{#subobject:a12a2a|Regimen=1}}) | ||
| m | 23:09 (cur | prev) . . (-1,443) . . Jwarner (talk | contribs) (→Pembrolizumab monotherapy) | ||
| m | 23:09 (cur | prev) . . (+2,506) . . Jwarner (talk | contribs) (→Cisplatin & Fluorouracil {{#subobject:4d9936|Regimen=1}}) | ||
| m | 23:05 (cur | prev) . . (-1,173) . . Jwarner (talk | contribs) (→Pembrolizumab + Cisplatin + 5-FU) | ||
| m | 23:00 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Pembrolizumab Monotherapy) | ||
| m | 22:59 (cur | prev) . . (+302) . . Jwarner (talk | contribs) (→Pembrolizumab Monotherapy) | ||
| 22:39 (cur | prev) . . (+39) . . Ivyabraham (talk | contribs) (→Regimen #subobject:82ca03) (Tag: Visual edit) | |||
| 22:36 (cur | prev) . . (+1,565) . . Ivyabraham (talk | contribs) (Added docetaxel + S-1 as adjuvant therapy option based on 2019 ASCO abstract) (Tag: Visual edit) | |||
| 22:16 (cur | prev) . . (+3,390) . . Ivyabraham (talk | contribs) (→Regorafenib monotherapy #subobject:022ef0) (Tag: Visual edit) |
| m 17:38 | Cholangiocarcinoma (diff | hist) . . (+8) . . Jwarner (talk | contribs) (→Ivosidenib {{#subobject:af0357|Regimen=1}}) |
| m 17:21 | Colon cancer (2 changes | history) . . (+522) . . [Jwarner (2×)] | ||
| m | 17:21 (cur | prev) . . (+64) . . Jwarner (talk | contribs) | ||
| m | 07:45 (cur | prev) . . (+458) . . Jwarner (talk | contribs) |
5 November 2019
| 16:37 | Cholangiocarcinoma (diff | hist) . . (+1,552) . . Ariseifter (talk | contribs) (Added ivosidenib (phase III) for IDH1 mutation. Presented at ESMO last month, not yet indexed on pubmed as far as I could see.) (Tag: Visual edit) |
